Abstract

Tobacco smoking has emerged as a risk factor for increasing the susceptibility to infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via increased expression of angiotensin-converting enzyme-2 (ACE2) in the lung, linked to coronavirus disease 2019 (COVID-19) development. Given the modifiable nature of electronic cigarettes and the delivery of high concentrations of nicotine, we investigate whether electronic cigarette vaping has the potential to increase susceptibility to SARS-CoV-2 infection. We exposed BEAS-2B cells (bronchial epithelium transformed with Ad12-SV40 2B) and primary small airway epithelial cells (SAECs) to electronic cigarette aerosol condensates produced from propylene glycol/vegetable glycerin or commercially bought e-liquid (±added nicotine) and cigarette smoke extract to investigate if electronic cigarette exposure, like cigarette smoke, increases the expression of ACE2 in lung epithelial cells. In BEAS-2B cells, cytotoxicity (CCK-8), membrane integrity (LDH), and ACE2 protein expression (immunofluorescence) were measured for both 4- and 24 h treatments in BEAS-2B cells and 4 h in SAECs; ACE2 gene expression was measured using quantitative polymerase chain reaction (qPCR) for 4 h treatment in BEAS-2B cells. Nicotine-free condensates and higher concentrations of nicotine-containing condensates were cytotoxic to BEAS-2B cells. Higher LDH release and reduced membrane integrity were seen in BEAS-2B cells treated for 24 h with higher concentrations of nicotine-containing condensates. ACE2 protein expression was observably increased in all treatments compared to cell controls, particularly for 24 h exposures. ACE2 gene expression was significantly increased in cells exposed to the locally bought e-liquid condensate with high nicotine concentration and cigarette smoke extract compared with cell controls. Our study suggests that vaping alone and smoking alone can result in an increase in lung ACE2 expression. Vaping and smoking are avoidable risk factors for COVID-19, which, if avoided, could help reduce the number of COVID-19 cases and the severity of the disease. This is the first study to utilize electronic cigarette aerosol condensates, novel and developed in our laboratory, for investigating ACE2 expression in human airway epithelial cells.

Highlights

  • A novel coronavirus emerged at the end of 2019, the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since consumed the planet, with the cruel development of coronavirus disease 2019 (COVID-19) in some [1,2]

  • cigarette smoke extract (CSE) (1%) treatment significantly reduced viability at both 4 h (Figure 2; p < 0.01) and 24 h (Figure 3; p < 0.05) in comparison with cell controls and independent of the original dimethyl sulfoxide (DMSO) solvent. 24 h post-treatment with nicotine-free Watermelon and menthol (WM) e-liquid and PG/VG condensates (Figure 3) resulted in total cell death at 1%, 0.5%, and 0.1% (p < 0.0001, p < 0.001) concentrations tested, with significant decrease observed in low concentrations of 0.05% for WM (p < 0.05) (Figure 3A)

  • Such reduction in viability was observed for higher concentrations (1%, 0.5%) of condensates without nicotine following 4 h treatment (p < 0.0001), which faded in lower concentration (0.1%, 0.05%) (p < 0.0001, p < 0.001) (Figure 2)

Read more

Summary

Introduction

A novel coronavirus emerged at the end of 2019, the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since consumed the planet, with the cruel development of coronavirus disease 2019 (COVID-19) in some [1,2]. This virus has resulted in one of the deadliest human pandemics in modern history [3]. R0 value estimates for SARS-CoV-2 range from 2.2 to as high as 6.47 [7,8,9] This pandemic is culminated by the perfect storm of a highly contractive and strongly transmissible nature

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.